← Open Payments lookup

JON FAILLA: Open Payments

NPI 1326474685 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$60,855 in 101 payments from 8 companies in 2025. Trend: 2023 $2,063 · 2024 $7,850 · 2025 $60,855

Speaker / faculty: $44,240Consulting: $10,568Food & beverage: $3,837Travel & lodging: $2,211
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.40$34,488
Teva Pharmaceuticals USA, Inc.22$14,301
Alkermes, Inc.23$11,356
E.R. Squibb & Sons, L.L.C.9$209
Janssen Pharmaceuticals, Inc2$169
Otsuka America Pharmaceutical, Inc.3$163
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$146
ABBVIE INC.1$24

Products named: INGREZZA, UZEDY, LYBALVI, AUSTEDO XR, COBENFY, CAPLYTA, ABILIFY MAINTENA, SPRAVATO.

Industry payments across NV — which companies pay providers there.